| Starting Price (public) | Published trainee and individual pricing available from the vendor; verify current offers in-store/quote | Published student pricing is shown publicly; clinician pricing varies and no single list price is publicly stated | Public pricing varies by region/role; pricing is available from the vendor and partner channels |
| Best For | Clinicians who prefer detailed narrative synthesis with references; used in training and ongoing education | Clinicians who prefer concise, directive evidence summaries with integrated drug information | Teams or regions aligned with BMJ editorial approaches; variable adoption by institution |
| Key Strength | Breadth and depth of content, long-standing market presence, and integrated workflow tools | Concise, outline-like presentation and integrated Micromedex drug content | Structured clinical guidance and differential support in selected modules |
| Key Weakness | Cost sensitivity, search and workflow friction for some users, and consumer-reported support/billing issues | Less narrative depth compared with UpToDate (per some community comparisons); pricing transparency varies | Adoption and integration vary by institution; content emphasis differs from UpToDate |